Pierre Nizet

PharmD : @CHUNantes - @Nantesuniv #clinicalpharmacy 🏥. PhD student : @SPHERE_U1246 #deprescribing 💊🚫. Membre com junior @SFPCOfficiel @ICOD2024

[Basic & Clinical Pharmacology & Toxicology @BasClinPharmTox]

1/5

Evaluation of the Perception of Deprescribing by French Pharmacy Students: A National Observational Study

New study by @Nizetpierre and colleagues – study highlights 👇

[Shoaib Alam @ShoaibAlamKhat2]

A Call to Reduce Sedative & #AnticholinergicMedications | @AGSJournal

A study finds 1 in 3 older people prescribed anticholinergic or #sedative drugs, with even higher rates in institutionalized patients. 📈

More #deprescribing is needed!

#Pharmacy
https://t.co/L5ChXLsUKO

[Amélie Cransac @AmelieCransac]

Pharmacy Education and Clinical Pharmacy Training in France 👍
@ANEPC_PharmClin
https://t.co/SgaIXqnYU3 #mdpipharmacy via @Pharmacy_MDPI

[ICOD 2 @ICOD2024]

The organizing committee is sad to let you go, but happy that everything went well! See you in 2 years, friends 🥰

[ICOD 2 @ICOD2024]

Everybody, let’s share some deprescribing interventions experienced all over the world 🌍 ! #oralcommunications @OptimisingRxUse

[deprescribing.org @deprescribing]

👏👏👏👏 to the @ICOD2024 Organizing Committee for their tremendous work on a fantastic scientific (+ social) program. We are live from Nantes 🇫🇷!

@DeprescribeNet @DeprescribeUS @DeprescribeAU @NDeprescribing

[Pierre Nizet @Nizetpierre]

@ICOD2024 is started !!!!

[Emily McDonald @DrEmilyMcD]

Happy international pharmacists day!! 🌸💫💖

@ICOD2024
@DeprescribeNet
@deprescribing

[ICOD 2 @ICOD2024]

The Organising Committee is finalising the last details of the conference! Are you ready folks? 🤩🤩🤩 Looking forward to seeing you!

[Pierre Nizet @Nizetpierre]

📄💊 Proud to share : Our article on French pain physicians' perceptions of opioid deprescribing in the chronic non-cancer pain is now online.

@AEVIN59467761 @HuonJeff @DeprescribeNet @DeprescribeAU @deprescribing @EDeprescribeN @DeprescribeUS

https://t.co/Rlo1xATlgf

[AEVIN @AEVIN59467761]

DEprescribing: Perceptions of PAtients living with advanced cancer. A multicentre, prospective mixed observational study protocol | PLOS ONE ⁦@HuonJeff⁩ ⁦@Nizetpierre⁩ ⁦@Fondationfrance⁩ New projet with our team with fondation de France https://t.co/f3GhDXabi7

[Jeff Huon @HuonJeff]

📣MedGé et Pharmaciens, si on vous proposait une formation sur « Comment déprescrire les BZD en pratique ? » 💊, qu’est ce que vous voudriez voir dedans et quel format serait le plus adapté ?
@NovaisTeddy @Nizetpierre @SFPCOfficiel

[JAGS @AGSJournal]

Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta-analysis. #geriatrics https://t.co/URPrirdr0S

[Jeff Huon @HuonJeff]

Pharmaciens, médecins, infirmiers… inscrivez-vous au congrès de déprescription ! (Dépêchez vous 😗)
26-27 septembre à Nantes, avec les grands noms de la déprescription, ça va être top !

[ICOD 2 @ICOD2024]

📣 ICOD2: Registrations now open!📣

In-person or virtual attendance, early-bird registration fee until June 15th.

More detailed info on the scientific program to come soon…

👇👇
https://t.co/GSlNF5Qbbh

⚠️ limited places ⚠️

[ICOD 2 @ICOD2024]

🔂 TIME EXTENSION 🔂 The call for abstracts will close on March 10th. Last call to share your research, clinical experience, or any workshop idea! Submit before it’s too late ⏰#ICOD2024
🔜 https://t.co/LyZwvfsTh4

[ICOD 2 @ICOD2024]

🚨 ⏰ *6 days* before the call for abstracts closes! Would you like to share your research or clinical experience? Do you have ideas for a workshop? Submit them before February 29! #ICOD2024
—> https://t.co/LyZwvfsTh4

[Jeff Huon @HuonJeff]

Go deprescribers!
Allez les collègues intéressés par la déprescription, on y va :-) #deprescribing

[ICOD 2 @ICOD2024]

⏱️Tik Tok⏱️16 days before the call for abstracts closes! Would you like to share your research or clinical experience? Do you have ideas for a workshop? Submit them before February 29! #ICOD2024

[RSAP Journal @RSAPjournal]

A systematic review shows that missing data & methods used to handle it were underreported in studies using the revised Pt Attitudes Toward Deprescribing questionnaire, which may impact interpretation. https://t.co/R4RpSkjZZe